Kelly Wemyss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kelly Wemyss has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Joanne E. Konkel
Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health Manchester Academic Health Science Centre, University of Manchester Manchester UK
10 shared publications - John R. Grainger
Lydia Becker Institute of Immunology and Inflammation Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
10 shared publications - Hayley Bridgeman
Lydia Becker Institute of Immunology and Inflammation Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
6 shared publications - Ian E. Prise
Lydia Becker Institute of Immunology and Inflammation Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
6 shared publications - Tovah N. Shaw
Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK
6 shared publications - Joshua R. Cox
Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health Manchester Academic Health Science Centre, University of Manchester Manchester UK
4 shared publications
Latest Publications
- 28 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (122)
Type I IFN–induced IFN-γ instructs monocyte-mediated systemic bacterial protection during type 2 intestinal helminth infection
Alterations to monocyte output and function occur during infections driving T helper 1 (T H 1)–type inflammation. The degree to which monocytes respond to infections initiating alternative types of responses is poorly understood. Here, we describe a distinct state of the monocyte compartment associated with type 2–polarizing intestinal helminths. Unexpectedly, the adapted monocyte state in a type 2 setting was associated with acquisition of an interferon (IFN) signature. This IFN-induced state provided helminth-infected animals with systemic protection against secondary bacterial infection and allowed for the development of effective type 2 immunity. This pathway of monocyte education was distinct from that in T H 1 settings and involved an endogenous bacteria–mediated induction of type I IFN that led to adaptive lymphocyte–dependent IFN-γ priming of monocytes. These findings reveal an IFN-driven mechanism of monocyte education that enables the host to be simultaneously protected against type 2 infections at barrier sites and type 1 infections in the circulation.
- 28 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (122)
Type I IFN–induced IFN-γ instructs monocyte-mediated systemic bacterial protection during type 2 intestinal helminth infection
Alterations to monocyte output and function occur during infections driving T helper 1 (T H 1)–type inflammation. The degree to which monocytes respond to infections initiating alternative types of responses is poorly understood. Here, we describe a distinct state of the monocyte compartment associated with type 2–polarizing intestinal helminths. Unexpectedly, the adapted monocyte state in a type 2 setting was associated with acquisition of an interferon (IFN) signature. This IFN-induced state provided helminth-infected animals with systemic protection against secondary bacterial infection and allowed for the development of effective type 2 immunity. This pathway of monocyte education was distinct from that in T H 1 settings and involved an endogenous bacteria–mediated induction of type I IFN that led to adaptive lymphocyte–dependent IFN-γ priming of monocytes. These findings reveal an IFN-driven mechanism of monocyte education that enables the host to be simultaneously protected against type 2 infections at barrier sites and type 1 infections in the circulation.
- Open Access
Specific Deletion of Interleukin‐1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke
Interleukin‐1 (IL‐1) signaling is a major driver of post‐ischemic neuroinflammation, yet the cell‐ and isoform‐specific roles of the two major IL‐1 receptor type 1 agonists, IL‐1α and IL‐1β, remain incompletely defined in the context of stroke. Microglia rapidly express IL‐1α after cerebral ischemia, whereas IL‐1β expression is delayed and restricted to a small subset of microglia and infiltrating immune cells. Here, we investigated for the first time the specific contribution of microglial‐derived IL‐1β to acute injury and post‐stroke neurorepair after transient middle cerebral artery occlusion in male and female mice, through microglial‐specific tamoxifen‐inducible Cre‐loxP‐mediated recombination. Deletion of microglial IL‐1β improved acute neurological outcomes, reduced neutrophil accumulation in the ischemic brain, and dampened systemic inflammatory cytokines. These effects were most evident during the acute phase and in females in mice. In contrast, long‐term functional recovery was largely unaffected. However, microglial IL‐1β deletion differentially regulated post‐stroke neurogenesis, enhancing subventricular zone neurogenic responses and ectopic neuroblast migration while limiting hippocampal neurogenesis. Together, these findings identify microglial IL‐1β as a key amplifier of early inflammatory injury after stroke, exerting region‐specific effects on neurogenic niches, and highlight distinct, non‐redundant roles for microglial IL‐1 isoforms in ischemic brain injury and repair.
Open AccessSpecific Deletion of Interleukin‐1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke
Interleukin‐1 (IL‐1) signaling is a major driver of post‐ischemic neuroinflammation, yet the cell‐ and isoform‐specific roles of the two major IL‐1 receptor type 1 agonists, IL‐1α and IL‐1β, remain incompletely defined in the context of stroke. Microglia rapidly express IL‐1α after cerebral ischemia, whereas IL‐1β expression is delayed and restricted to a small subset of microglia and infiltrating immune cells. Here, we investigated for the first time the specific contribution of microglial‐derived IL‐1β to acute injury and post‐stroke neurorepair after transient middle cerebral artery occlusion in male and female mice, through microglial‐specific tamoxifen‐inducible Cre‐loxP‐mediated recombination. Deletion of microglial IL‐1β improved acute neurological outcomes, reduced neutrophil accumulation in the ischemic brain, and dampened systemic inflammatory cytokines. These effects were most evident during the acute phase and in females in mice. In contrast, long‐term functional recovery was largely unaffected. However, microglial IL‐1β deletion differentially regulated post‐stroke neurogenesis, enhancing subventricular zone neurogenic responses and ectopic neuroblast migration while limiting hippocampal neurogenesis. Together, these findings identify microglial IL‐1β as a key amplifier of early inflammatory injury after stroke, exerting region‐specific effects on neurogenic niches, and highlight distinct, non‐redundant roles for microglial IL‐1 isoforms in ischemic brain injury and repair.
- Open Access
- 21 April 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (5)
CD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-β
Macrophages localize in sub-tissular niches associated with their ontogeny and activity. In the intestine, a paradigm has emerged that long-lived macrophages are present in the muscular layer, while highly monocyte-replenished populations are found in the lamina propria (LP). Whether long-lived macrophages are restricted in such a simplified manner has not been well explored. Moreover, the impact of specific gut-associated factors on macrophage identity across intestinal tissue layers is unknown. We generated scRNA-seq data from WT and Ccr2−/− mice to identify phenotypic features of long-lived macrophage populations in distinct intestinal layers and identified CD163 as a marker to distinguish submucosal/muscularis (S/M) from LP macrophages. Challenging the emerging paradigm, long-lived macrophages were found in the LP and S/M, with distinct transcriptomes and responsiveness to proinflammatory stimuli. Employing transgenic mice, we demonstrate a critical role for TGF-β signalling in maintaining the identity of long-lived LP but not S/M macrophages and that macrophage-derived TGF-β1 is required to instruct intestinal macrophage identity after development.
- 21 April 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (5)
Open AccessCD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-β
Macrophages localize in sub-tissular niches associated with their ontogeny and activity. In the intestine, a paradigm has emerged that long-lived macrophages are present in the muscular layer, while highly monocyte-replenished populations are found in the lamina propria (LP). Whether long-lived macrophages are restricted in such a simplified manner has not been well explored. Moreover, the impact of specific gut-associated factors on macrophage identity across intestinal tissue layers is unknown. We generated scRNA-seq data from WT and Ccr2−/− mice to identify phenotypic features of long-lived macrophage populations in distinct intestinal layers and identified CD163 as a marker to distinguish submucosal/muscularis (S/M) from LP macrophages. Challenging the emerging paradigm, long-lived macrophages were found in the LP and S/M, with distinct transcriptomes and responsiveness to proinflammatory stimuli. Employing transgenic mice, we demonstrate a critical role for TGF-β signalling in maintaining the identity of long-lived LP but not S/M macrophages and that macrophage-derived TGF-β1 is required to instruct intestinal macrophage identity after development.
- Open Access
Specific deletion of interleukin-1 beta in microglia improves acute outcome and modulates neurogenesis after ischemic stroke
Interleukin-1 (IL-1) signaling is a major driver of post-ischemic neuroinflammation, yet the cell- and isoform-specific roles of the two major IL-1 receptor type 1 agonists, IL-1α and IL-1β, remain incompletely defined in the context of stroke. Microglia rapidly express IL-1α after cerebral ischemia, whereas IL-1β expression is delayed and restricted to a small subset of microglia and infiltrating immune cells. Here, we investigated for the first time the specific contribution of microglial-derived IL-1β to acute injury and post-stroke neurorepair after transient middle cerebral artery occlusion in male and female mice, through microglial-specific tamoxifen-inducible Cre-loxP-mediated recombination. Deletion of microglial IL-1β improved acute neurological outcome, reduced neutrophil accumulation in the ischemic brain and dampened systemic inflammatory cytokines. These effects were most evident during the acute phase and in female in mice. In contrast, long-term functional recovery was largely unaffected. However, microglial IL-1β deletion differentially regulated post-stroke neurogenesis, enhancing subventricular zone neurogenic responses and ectopic neuroblast migration while limiting hippocampal neurogenesis. Together, these findings identify microglial IL-1β as a key amplifier of early inflammatory injury after stroke, exerting region-specific effects on neurogenic niches, and highlight distinct, non-redundant roles for microglial IL-1 isoforms in ischemic brain injury and repair.
Open AccessSpecific deletion of interleukin-1 beta in microglia improves acute outcome and modulates neurogenesis after ischemic stroke
Interleukin-1 (IL-1) signaling is a major driver of post-ischemic neuroinflammation, yet the cell- and isoform-specific roles of the two major IL-1 receptor type 1 agonists, IL-1α and IL-1β, remain incompletely defined in the context of stroke. Microglia rapidly express IL-1α after cerebral ischemia, whereas IL-1β expression is delayed and restricted to a small subset of microglia and infiltrating immune cells. Here, we investigated for the first time the specific contribution of microglial-derived IL-1β to acute injury and post-stroke neurorepair after transient middle cerebral artery occlusion in male and female mice, through microglial-specific tamoxifen-inducible Cre-loxP-mediated recombination. Deletion of microglial IL-1β improved acute neurological outcome, reduced neutrophil accumulation in the ischemic brain and dampened systemic inflammatory cytokines. These effects were most evident during the acute phase and in female in mice. In contrast, long-term functional recovery was largely unaffected. However, microglial IL-1β deletion differentially regulated post-stroke neurogenesis, enhancing subventricular zone neurogenic responses and ectopic neuroblast migration while limiting hippocampal neurogenesis. Together, these findings identify microglial IL-1β as a key amplifier of early inflammatory injury after stroke, exerting region-specific effects on neurogenic niches, and highlight distinct, non-redundant roles for microglial IL-1 isoforms in ischemic brain injury and repair.
- Open Access
- 25 November 2025
- Published by Wiley in Barrier Immunity
- Vol. 1 (1) , 7-19
TGFβ Plays a Minimal Role in Supporting Th17 Cell Phenotype Post Differentiation
Th17 cells can adopt different functional capabilities in response to environmental stimuli, exhibiting functional plasticity, contributing to both pathogenic autoinflammation but also vital homeostatic immune regulation, particularly at mucosal barriers. However, the upstream signals regulating Th17 cell plasticity and stability remain to be fully outlined. Here, we examined whether the cytokine TGFβ contributed to Th17 cell functional capabilities following differentiation. We utilized an IL‐17A‐specific cre to delete TGFβ receptor II in IL‐17‐producing cells, alongside fate‐mapping cre‐positive cells, to ascertain the role of TGFβ in supporting Th17 cell activity. TGFβR‐deficient Th17 cells were expanded at both mucosal barriers and within lymphoid tissues. However, contrasting previous studies, we show that in both steady state and following induction of inflammation, TGFβR‐deficient Th17 cells remain incredibly stable. We show that TGFβR‐deficient Th17 cells still predominantly produce IL‐17A, express the canonical Th17 cell transcription factor RORγt, and exhibit no altered capacity to produce additional cytokines, indicating TGFβ plays a redundant role in limiting or tailoring the activity of differentiated Th17 cells. However, upon transfer into a lymphopenic environment, TGFβR‐deficient Th17 cells exhibit substantive instability compared to TGFβR‐sufficient control cells, dramatically increasing IFNγ and reducing IL‐17A production, transdifferentiating into Th1‐like exTh17 cells. Thus, our data provide crucial insights into the importance of TGFβ in tailoring Th17 cells, refining our understanding to demonstrate that in lymphocyte‐replete hosts, even in the presence of inflammatory signals, TGFβ plays a limited role in maintaining Th17 cell phenotypes.
- 25 November 2025
- Published by Wiley in Barrier Immunity
- Vol. 1 (1) , 7-19
Open AccessTGFβ Plays a Minimal Role in Supporting Th17 Cell Phenotype Post Differentiation
Th17 cells can adopt different functional capabilities in response to environmental stimuli, exhibiting functional plasticity, contributing to both pathogenic autoinflammation but also vital homeostatic immune regulation, particularly at mucosal barriers. However, the upstream signals regulating Th17 cell plasticity and stability remain to be fully outlined. Here, we examined whether the cytokine TGFβ contributed to Th17 cell functional capabilities following differentiation. We utilized an IL‐17A‐specific cre to delete TGFβ receptor II in IL‐17‐producing cells, alongside fate‐mapping cre‐positive cells, to ascertain the role of TGFβ in supporting Th17 cell activity. TGFβR‐deficient Th17 cells were expanded at both mucosal barriers and within lymphoid tissues. However, contrasting previous studies, we show that in both steady state and following induction of inflammation, TGFβR‐deficient Th17 cells remain incredibly stable. We show that TGFβR‐deficient Th17 cells still predominantly produce IL‐17A, express the canonical Th17 cell transcription factor RORγt, and exhibit no altered capacity to produce additional cytokines, indicating TGFβ plays a redundant role in limiting or tailoring the activity of differentiated Th17 cells. However, upon transfer into a lymphopenic environment, TGFβR‐deficient Th17 cells exhibit substantive instability compared to TGFβR‐sufficient control cells, dramatically increasing IFNγ and reducing IL‐17A production, transdifferentiating into Th1‐like exTh17 cells. Thus, our data provide crucial insights into the importance of TGFβ in tailoring Th17 cells, refining our understanding to demonstrate that in lymphocyte‐replete hosts, even in the presence of inflammatory signals, TGFβ plays a limited role in maintaining Th17 cell phenotypes.
- Open Access
- 31 May 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (8)
Th17-to-Tfh plasticity during periodontitis limits disease pathology
Th17 cell plasticity is crucial for development of autoinflammatory disease pathology. Periodontitis is a prevalent inflammatory disease where Th17 cells mediate key pathological roles, yet whether they exhibit any functional plasticity remains unexplored. We found that during periodontitis, gingival IL-17 fate-mapped T cells still predominantly produce IL-17A, with little diversification of cytokine production. However, plasticity of IL-17 fate-mapped cells did occur during periodontitis, but in the gingiva draining lymph node. Here, some Th17 cells acquired features of Tfh cells, a functional plasticity that was dependent on IL-6. Notably, Th17-to-Tfh diversification was important to limit periodontitis pathology. Preventing Th17-to-Tfh plasticity resulted in elevated periodontal bone loss that was not simply due to increased proportions of conventional Th17 cells. Instead, loss of Th17-to-Tfh cells resulted in reduced IgG levels within the oral cavity and a failure to restrict the biomass of the oral commensal community. Thus, our data identify a novel protective function for a subset of otherwise pathogenic Th17 cells during periodontitis.
- 31 May 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (8)
Open AccessTh17-to-Tfh plasticity during periodontitis limits disease pathology
Th17 cell plasticity is crucial for development of autoinflammatory disease pathology. Periodontitis is a prevalent inflammatory disease where Th17 cells mediate key pathological roles, yet whether they exhibit any functional plasticity remains unexplored. We found that during periodontitis, gingival IL-17 fate-mapped T cells still predominantly produce IL-17A, with little diversification of cytokine production. However, plasticity of IL-17 fate-mapped cells did occur during periodontitis, but in the gingiva draining lymph node. Here, some Th17 cells acquired features of Tfh cells, a functional plasticity that was dependent on IL-6. Notably, Th17-to-Tfh diversification was important to limit periodontitis pathology. Preventing Th17-to-Tfh plasticity resulted in elevated periodontal bone loss that was not simply due to increased proportions of conventional Th17 cells. Instead, loss of Th17-to-Tfh cells resulted in reduced IgG levels within the oral cavity and a failure to restrict the biomass of the oral commensal community. Thus, our data identify a novel protective function for a subset of otherwise pathogenic Th17 cells during periodontitis.
- Open Access
- 7 February 2024
- Published by Elsevier in Matrix Biology
- Vol. 127, 23-37
Kidney resident macrophages have distinct subsets and multifunctional roles
- 7 February 2024
- Published by Elsevier in Matrix Biology
- Vol. 127, 23-37
Open AccessKidney resident macrophages have distinct subsets and multifunctional roles
- Open Access
CD163 and Tim-4 identify resident intestinal macrophages across sub-tissular regions that are spatially regulated by TGF-β
In bodily organs, macrophages are localised in poorly understood tissular and sub-tissular niches associated with defined macrophage ontogeny and activity. In the intestine, a paradigm is emerging that long-lived macrophages are dominantly present in the muscular layer, while highly monocyte-replenished populations are found in the lamina propria beneath the epithelial barrier. Whether longevity is restricted in such a simplified manner has not been well explored. Moreover, the impact of specific gut-associated factors on long-lived macrophage functionality and niche occupancy is unknown. We generated sc-RNA-Seq data from wild-type and Ccr2 −/− mice to identify phenotypic features of long-lived macrophage populations in distinct intestinal niches and identified CD163 as a useful marker to distinguish submucosal/muscularis (S/M) from lamina propria (LP) macrophages. Challenging the emerging paradigm, long-lived macrophages, identified by Tim-4 expression, were found in the LP and S/M. Long-lived LP macrophages are restrained in their response to proinflammatory stimulation compared to short-lived populations in the same location, and to the long-lived population within the S/M. Employing a novel Timd4 cre Tgfbr2 fl/fl mouse line we demonstrate distinct functions of TGF-β on long-lived macrophages in these two compartments. Importantly, in Timd4 cre Tgfbr2 fl/fl mice, zonation of CD163 + macrophages in the S/M was lost, suggesting TGF-β plays an unappreciated role in positioning of macrophages in the tissue. These data highlight the importance of considering ontogeny and niche when assessing the action of key intestinal regulatory signals.
Open AccessCD163 and Tim-4 identify resident intestinal macrophages across sub-tissular regions that are spatially regulated by TGF-β
In bodily organs, macrophages are localised in poorly understood tissular and sub-tissular niches associated with defined macrophage ontogeny and activity. In the intestine, a paradigm is emerging that long-lived macrophages are dominantly present in the muscular layer, while highly monocyte-replenished populations are found in the lamina propria beneath the epithelial barrier. Whether longevity is restricted in such a simplified manner has not been well explored. Moreover, the impact of specific gut-associated factors on long-lived macrophage functionality and niche occupancy is unknown. We generated sc-RNA-Seq data from wild-type and Ccr2 −/− mice to identify phenotypic features of long-lived macrophage populations in distinct intestinal niches and identified CD163 as a useful marker to distinguish submucosal/muscularis (S/M) from lamina propria (LP) macrophages. Challenging the emerging paradigm, long-lived macrophages, identified by Tim-4 expression, were found in the LP and S/M. Long-lived LP macrophages are restrained in their response to proinflammatory stimulation compared to short-lived populations in the same location, and to the long-lived population within the S/M. Employing a novel Timd4 cre Tgfbr2 fl/fl mouse line we demonstrate distinct functions of TGF-β on long-lived macrophages in these two compartments. Importantly, in Timd4 cre Tgfbr2 fl/fl mice, zonation of CD163 + macrophages in the S/M was lost, suggesting TGF-β plays an unappreciated role in positioning of macrophages in the tissue. These data highlight the importance of considering ontogeny and niche when assessing the action of key intestinal regulatory signals.
- Open Access
- 30 July 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (7) , e1009768
Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages
The intestinal nematode parasite Trichuris muris dwells in the caecum and proximal colon driving an acute resolving intestinal inflammation dominated by the presence of macrophages. Notably, these macrophages are characterised by their expression of RELMα during the resolution phase of the infection. The RELMα+ macrophage phenotype associates with the presence of alternatively activated macrophages and work in other model systems has demonstrated that the balance of classically and alternatively activated macrophages is critically important in enabling the resolution of inflammation. Moreover, in the context of type 2 immunity, RELMα+ alternatively activated macrophages are associated with the activation of macrophages via the IL4Rα. Despite a breadth of inflammatory pathologies associated with the large intestine, including those that accompany parasitic infection, it is not known how colonic macrophages are activated towards an alternatively activated phenotype. Here, we address this important knowledge gap by using Trichuris muris infection, in combination with transgenic mice (IL4Rαfl/fl.CX3CR1Cre) and IL4Rα-deficient/wild-type mixed bone marrow chimaeras. We make the unexpected finding that education of colonic macrophages towards a RELMα+, alternatively activated macrophage phenotype during T. muris infection does not require IL4Rα expression on macrophages. Further, this independence is maintained even when the mice are treated with an anti-IFNγ antibody during infection to create a strongly polarised Th2 environment. In contrast to RELMα, PD-L2 expression on macrophages post infection was dependent on IL4Rα signalling in the macrophages. These novel data sets are important, revealing a surprising cell-intrinsic IL4R alpha independence of the colonic RELMα+ alternatively activated macrophage during Trichuris muris infection.
- 30 July 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (7) , e1009768
Open AccessTrichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages
The intestinal nematode parasite Trichuris muris dwells in the caecum and proximal colon driving an acute resolving intestinal inflammation dominated by the presence of macrophages. Notably, these macrophages are characterised by their expression of RELMα during the resolution phase of the infection. The RELMα+ macrophage phenotype associates with the presence of alternatively activated macrophages and work in other model systems has demonstrated that the balance of classically and alternatively activated macrophages is critically important in enabling the resolution of inflammation. Moreover, in the context of type 2 immunity, RELMα+ alternatively activated macrophages are associated with the activation of macrophages via the IL4Rα. Despite a breadth of inflammatory pathologies associated with the large intestine, including those that accompany parasitic infection, it is not known how colonic macrophages are activated towards an alternatively activated phenotype. Here, we address this important knowledge gap by using Trichuris muris infection, in combination with transgenic mice (IL4Rαfl/fl.CX3CR1Cre) and IL4Rα-deficient/wild-type mixed bone marrow chimaeras. We make the unexpected finding that education of colonic macrophages towards a RELMα+, alternatively activated macrophage phenotype during T. muris infection does not require IL4Rα expression on macrophages. Further, this independence is maintained even when the mice are treated with an anti-IFNγ antibody during infection to create a strongly polarised Th2 environment. In contrast to RELMα, PD-L2 expression on macrophages post infection was dependent on IL4Rα signalling in the macrophages. These novel data sets are important, revealing a surprising cell-intrinsic IL4R alpha independence of the colonic RELMα+ alternatively activated macrophage during Trichuris muris infection.
- Open Access
- 26 February 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (4)
Hematopoietic stem and progenitor cells are present in healthy gingiva tissue
Hematopoietic stem cells reside in the bone marrow, where they generate the effector cells that drive immune responses. However, in response to inflammation, some hematopoietic stem and progenitor cells (HSPCs) are recruited to tissue sites and undergo extramedullary hematopoiesis. Contrasting with this paradigm, here we show residence and differentiation of HSPCs in healthy gingiva, a key oral barrier in the absence of overt inflammation. We initially defined a population of gingiva monocytes that could be locally maintained; we subsequently identified not only monocyte progenitors but also diverse HSPCs within the gingiva that could give rise to multiple myeloid lineages. Gingiva HSPCs possessed similar differentiation potentials, reconstitution capabilities, and heterogeneity to bone marrow HSPCs. However, gingival HSPCs responded differently to inflammatory insults, responding to oral but not systemic inflammation. Combined, we highlight a novel pathway of myeloid cell development at a healthy barrier, defining a gingiva-specific HSPC network that supports generation of a proportion of the innate immune cells that police this barrier.
- 26 February 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (4)
Open AccessHematopoietic stem and progenitor cells are present in healthy gingiva tissue
Hematopoietic stem cells reside in the bone marrow, where they generate the effector cells that drive immune responses. However, in response to inflammation, some hematopoietic stem and progenitor cells (HSPCs) are recruited to tissue sites and undergo extramedullary hematopoiesis. Contrasting with this paradigm, here we show residence and differentiation of HSPCs in healthy gingiva, a key oral barrier in the absence of overt inflammation. We initially defined a population of gingiva monocytes that could be locally maintained; we subsequently identified not only monocyte progenitors but also diverse HSPCs within the gingiva that could give rise to multiple myeloid lineages. Gingiva HSPCs possessed similar differentiation potentials, reconstitution capabilities, and heterogeneity to bone marrow HSPCs. However, gingival HSPCs responded differently to inflammatory insults, responding to oral but not systemic inflammation. Combined, we highlight a novel pathway of myeloid cell development at a healthy barrier, defining a gingiva-specific HSPC network that supports generation of a proportion of the innate immune cells that police this barrier.